A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Paul Johnson
Advertisement
Paul Johnson is scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles by Paul Johnson
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement